UNSPSC 51332814: Levomepromazine or methotrimeprazine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51332814

Definition

This classification denotes a phenothiazine with the molecular formula C19H24N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9G0LAW7ATQ, chemically known as 10h-phenothiazine-10-propanamine, 2-methoxy-n,n,beta-trimethyl-, (r)- but generally known as levomepromazine, which bears US NIH Compound Identifier 3916. European Medicines Agency schedules Levomepromazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08476MIG.

Read the full definition

The term LEVOMEPROMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules levomepromazine in its Anatomical Therapeutic Chemical (ATC) Classification. LEVOMEPROMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Levomepromazine or methotrimeprazine bears US NLM identifiers UMLS ID C0025678 and NCI Concept Code C66118. SMILES: S1C2C(N(CC(CN(C)C)C)C3C1CCCC3)CC(OC)CC2.

About UNSPSC 51332814

UNSPSC 51332814 Levomepromazine or methotrimeprazine is a Commodity code nominally associated with a single pharmaceutical compound, but the recent state and local opportunities tagged to this code show little relevant activity. The three most recent solicitations tagged to this code address naloxone and drug deactivation systems, a therapeutic pharmacy initiative for direct-to-manufacturer prescriptions, and a multi-state cooperative purchasing agreement for generic pharmaceuticals and over-the-counter products—none of which are levomepromazine or closely related antipsychotic medications. The mismatch between the code's nominal scope and the work actually being procured suggests this code sees minimal or mislabeled activity in state and local procurement.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026, reflecting a health-department focus on overdose response rather than psychiatric pharmaceuticals. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription programs, a market-intelligence exercise preceding formal procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802) with a March 26, 2026, deadline for generic multi-source pharmaceuticals and OTC products to supply state and local government facilities across participating jurisdictions including Oregon. None of these opportunities relate to levomepromazine supply or specialty antipsychotic procurement. State and local buyers pursuing this code should verify the correct UNSPSC classification before pursuing or tracking opportunities.

Quick answers

What is UNSPSC 51332814?

UNSPSC 51332814 is Levomepromazine or methotrimeprazine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51332814?

UNSPSC 51332814 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51332814

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code